Abstract
The susceptibilities of 138 clinical isolates of Arcanobacterium haemolyticum to 11 antimicrobial agents were tested. All strains were susceptible to phenoxymethylpenicillin, cephalosporins, erythromycin, azithromycin, clindamycin, vancomycin, doxycycline, and ciprofloxacin but were resistant to trimethoprim-sulfamethoxazole.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Banck G., Nyman M. Tonsillitis and rash associated with Corynebacterium haemolyticum. J Infect Dis. 1986 Dec;154(6):1037–1040. doi: 10.1093/infdis/154.6.1037. [DOI] [PubMed] [Google Scholar]
- Collins M. D., Jones D., Schofield G. M. Reclassification of 'Corynebacterium haemolyticum' (MacLean, Liebow & Rosenberg) in the genus Arcanobacterium gen.nov. as Arcanobacterium haemolyticum nom.rev., comb.nov. J Gen Microbiol. 1982 Jun;128(6):1279–1281. doi: 10.1099/00221287-128-6-1279. [DOI] [PubMed] [Google Scholar]
- French G., Abdulla Y., Heathcock R., Poston S., Cameron J. Vancomycin resistance in south London. Lancet. 1992 Mar 28;339(8796):818–819. doi: 10.1016/0140-6736(92)91954-7. [DOI] [PubMed] [Google Scholar]
- Lämmler C., Blobel H. Comparative studies on Actinomyces pyogenes and Arcanobacterium haemolyticum. Med Microbiol Immunol. 1988;177(2):109–114. doi: 10.1007/BF00189532. [DOI] [PubMed] [Google Scholar]
- Nyman M., Banck G., Thore M. Penicillin tolerance in Arcanobacterium haemolyticum. J Infect Dis. 1990 Feb;161(2):261–265. doi: 10.1093/infdis/161.2.261. [DOI] [PubMed] [Google Scholar]
- Waagner D. C. Arcanobacterium haemolyticum: biology of the organism and diseases in man. Pediatr Infect Dis J. 1991 Dec;10(12):933–939. [PubMed] [Google Scholar]